K

KCK LTD. Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for KCK LTD. with $15.1M in long positions as of Q3 2025, 100% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$15.1M
Top 10 Concentration
100%
Top Sector
Healthcare (100%)
US Exposure
100%
Market Cap Focus
Micro Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 99.70%Healthcare
Healthcare
99.70%

Industry Breakdown

1 industry across all sectors

Medical - Devices: 99.66%Medical - Devices
Medical - Devices
Healthcare
99.66%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Micro Cap ($50M - $300M): 99.66%Micro Cap ($50M - $300M)Nano Cap (< $50M): 0.34%
Micro Cap ($50M - $300M)
99.66%
Nano Cap (< $50M)
0.34%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($15.1M)
2 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
0 quarters
Avg. Top 20
0 quarters
Avg. All Positions
0 quarters
Median Holding Period
0 quarters
Persistence Rate
-
Persistent Holdings Weight
-
Persistent Positions
0
Longest Held
Rein Therapeutics, Inc. Common Stock logo
Rein Therapeutics, Inc. Common StockRNTX - 0 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
50.00%
Largest Position
Sight Sciences, Inc. Common Stock logo
Sight Sciences, Inc. Common StockSGHT - 99.66%
Largest Ownership Stake
Sight Sciences, Inc. Common Stock logo
Sight Sciences, Inc. Common StockSGHT - 8.35%
Avg. Ownership Stake
8.33%
Ownership Stake >5%
1
Ownership Stake >1%
1

Historical (Since Q4 2021)

Avg. New Position
20.01%
Avg. Ownership Stake
14.74%
Largest Position
Sight Sciences, Inc. Common Stock logo
Sight Sciences, Inc. Common StockSGHT - 99.66% (Q3 2025)
Largest Ownership Stake
Neuropace, Inc. Common Stock logo
Neuropace, Inc. Common StockNPCE - 23.12% (Q4 2021)

Portfolio Turnover

Current Quarter

Turnover Ratio
0.0%
Value Traded
$0.00
Positions Added
0
Positions Exited
0

Historical (Since Q4 2021)

Avg. Turnover Ratio
5.5%
Avg. Positions Added
1
Avg. Positions Exited
0
Highest Turnover
50.0%
Q4 2021

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.